Related references
Note: Only part of the references are listed.Demonstration of Plasmid-Mediated Drug Resistance in Mycobacterium abscessus
Cristianne Kayoko Matsumoto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
Isabelle Lerat et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence
Jakko van Ingen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections
C. Magis-Escurra et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Mycobacterium iranicum sp nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents
Hasan Shojaei et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2013)
Adherence and biofilm formation of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium abscessus to household plumbing materials
S. N. Mullis et al.
JOURNAL OF APPLIED MICROBIOLOGY (2013)
In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
Jakko van Ingen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Therapeutic Drug Monitoring in the Treatment of Mycobacterium avium Complex Lung Disease
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria
Diane Houben et al.
CELLULAR MICROBIOLOGY (2012)
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
J. W. Mouton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
Jakko van Ingen et al.
DRUG RESISTANCE UPDATES (2012)
Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?
Jakko van Ingen et al.
INFECTION GENETICS AND EVOLUTION (2012)
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST
Katja Lucke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing
Sylvaine Bastian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Jakko van Ingen et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
Julie Jarand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium avium
Devyani Deshpande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci
Ana Lucia Souza Antunes et al.
APMIS (2010)
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections
Rachel M. Thomson
EMERGING INFECTIOUS DISEASES (2010)
Antibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients
Kyeongman Jeon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
Kevin A. Nash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparison of three methods for susceptibility testing of Mycobacterium avium subsp paratuberculosis to 11 antimicrobial drugs
Manju Y. Krishnan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment
J. O. Falkinham
JOURNAL OF APPLIED MICROBIOLOGY (2009)
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis
Timothy P. Stinear et al.
GENOME RESEARCH (2008)
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
P. A. Jenkins et al.
THORAX (2008)
The early bactericidal activity of anti-tuberculosis drugs: a literature review
P. R. Donald et al.
TUBERCULOSIS (2008)
Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1) -: Report of the subcommittee on antimicrobial susceptibility testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
F. Drobniewski et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003
Theodore K. Marras et al.
THORAX (2007)
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Yoshihiro Kobashi et al.
RESPIRATORY MEDICINE (2007)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Intrinsic macrolide resistance in rapidly growing mycobacteria
Kevin A. Nash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004 -: Clinical features, drug susceptibility, and outcome
D Shitrit et al.
CHEST (2006)
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum
S Ramón-García et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis
XZ Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex
GL Woods et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Sixty-three cases of Mycobacterium marinum infection -: Clinical features, treatment, and antibiotic susceptibility of causative isolates
A Aubry et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations
JL Klein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis
PEA Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Antibiotic susceptibility pattern of Mycobacterium marinum
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
